IL140222A0 - A method and diagnostic kit for detecting alzheimer's disease - Google Patents
A method and diagnostic kit for detecting alzheimer's diseaseInfo
- Publication number
- IL140222A0 IL140222A0 IL14022299A IL14022299A IL140222A0 IL 140222 A0 IL140222 A0 IL 140222A0 IL 14022299 A IL14022299 A IL 14022299A IL 14022299 A IL14022299 A IL 14022299A IL 140222 A0 IL140222 A0 IL 140222A0
- Authority
- IL
- Israel
- Prior art keywords
- disease
- diagnostic kit
- detecting alzheimer
- alzheimer
- detecting
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 238000009007 Diagnostic Kit Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/096,335 US6458549B2 (en) | 1998-06-11 | 1998-06-11 | Methods of diagnosing renal salt wasting syndrome and Alzheimer's disease and methods of treating the same |
| PCT/US1999/013135 WO1999064621A1 (en) | 1998-06-11 | 1999-06-10 | Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL140222A0 true IL140222A0 (en) | 2002-02-10 |
Family
ID=22256880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14022299A IL140222A0 (en) | 1998-06-11 | 1999-06-10 | A method and diagnostic kit for detecting alzheimer's disease |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US6458549B2 (de) |
| EP (1) | EP1109929A4 (de) |
| AU (1) | AU4560299A (de) |
| CA (1) | CA2334892A1 (de) |
| IL (1) | IL140222A0 (de) |
| WO (1) | WO1999064621A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE281432T1 (de) | 1999-03-05 | 2004-11-15 | Univ Duke | C-16 ungesätigte fp-selektive prostaglandin analoge |
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| JP3752219B2 (ja) * | 2000-07-21 | 2006-03-08 | マルハ株式会社 | 痴呆性疾患の鑑別方法 |
| EP1223534A1 (de) * | 2001-01-14 | 2002-07-17 | Katz, Emil | Peptide, welche für spezifische Polypeptide repräsentativ sind, gegen diese Peptide gerichtete Antikörper, sowie Methoden, Systeme und Kits zur Herstellung und Verwendung dieser Peptide und Antikörper |
| JP2003284574A (ja) * | 2001-10-03 | 2003-10-07 | Pfizer Prod Inc | 核酸分子、ポリペプチド、ならびにアルツハイマー病の診断および処置を含むそれらの使用 |
| WO2003039475A2 (en) * | 2001-11-07 | 2003-05-15 | Millennium Pharmaceuticals, Inc. | Methods of identifying and using modulators of fractalkine receptor |
| US20030195431A1 (en) * | 2002-04-10 | 2003-10-16 | Sukhatme Vikas P. | Observation of effects of body fluids on indicator cells for disease diagnosis |
| US20070003992A1 (en) * | 2003-04-09 | 2007-01-04 | Pentyala Srinivas N | Methods and kits for detecting cerebrospinal fluid in a sample |
| US20040203079A1 (en) * | 2003-04-09 | 2004-10-14 | Research Foundation Of The State University Of New York | Methods and kits for detecting cerebrospinal fluid in a sample |
| US8003765B2 (en) * | 2003-04-09 | 2011-08-23 | Stony Brook Anaesthesiology, University Faculty Practice Corporation | Methods, antibodies and kits for detecting cerebrospinal fluid in a sample |
| US7851172B2 (en) * | 2006-07-25 | 2010-12-14 | University Of Kentucky Research Foundation | Biomarkers of mild cognitive impairment and alzheimer's disease |
| JP2021528476A (ja) * | 2018-06-28 | 2021-10-21 | サルアクア ダイアグノスティックス， インコーポレイテッド | ハプトグロビン関連タンパク質と関係する組成物および方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846220A (en) * | 1996-04-30 | 1998-12-08 | Medtronic, Inc. | Therapeutic method for treatment of Alzheimer's disease |
| CA2225270A1 (en) * | 1996-12-23 | 1998-06-23 | Mount Sinai Hospital Corporation | Method for quantitating prostaglandin d synthase in biological samples |
-
1998
- 1998-06-11 US US09/096,335 patent/US6458549B2/en not_active Expired - Fee Related
-
1999
- 1999-06-10 AU AU45602/99A patent/AU4560299A/en not_active Abandoned
- 1999-06-10 WO PCT/US1999/013135 patent/WO1999064621A1/en not_active Ceased
- 1999-06-10 IL IL14022299A patent/IL140222A0/xx unknown
- 1999-06-10 CA CA002334892A patent/CA2334892A1/en not_active Abandoned
- 1999-06-10 EP EP99928559A patent/EP1109929A4/de not_active Withdrawn
-
2002
- 2002-06-25 US US10/180,712 patent/US20020197652A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999064621A1 (en) | 1999-12-16 |
| US20020197652A1 (en) | 2002-12-26 |
| EP1109929A4 (de) | 2004-12-22 |
| EP1109929A1 (de) | 2001-06-27 |
| US20010021508A1 (en) | 2001-09-13 |
| CA2334892A1 (en) | 1999-12-16 |
| US6458549B2 (en) | 2002-10-01 |
| AU4560299A (en) | 1999-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103838A3 (en) | Alzheimer's disease secretase | |
| AU3891499A (en) | Diagnostic tests for alzheimer's disease | |
| AU5508798A (en) | Diagnostic and therapeutic reagents for alzheimer's disease | |
| EP0773797A4 (de) | Verfahren zur diagnose der alzheimer'schen erkrankung | |
| EP1024746A4 (de) | Vorrichtung und verfahren zum ermitteln der nüchternheit einer person | |
| EP1043991A4 (de) | Behandlung der alzheimer-erkrankung | |
| IL126534A0 (en) | Methods of diagnosing clinical subtypes of crohn's disease and a kit for diagnosing the same | |
| GB2328024B (en) | Method for sensing and estimating the shape and location of oil-water interfaces in a well | |
| EP0951293A4 (de) | Verfahren zur behandlung von alzheimer krankheit | |
| PL348226A1 (en) | Compounds for the antemortem diagnosis of alzheimer's disease and in vivo | |
| AU2002219824A1 (en) | Compositions and methods for diagnosing alzheimer's disease | |
| AU2610901A (en) | Predictive diagnostic for alzheimer's disease | |
| IL140222A0 (en) | A method and diagnostic kit for detecting alzheimer's disease | |
| AU7708498A (en) | Nematode model for alzheimer's disease | |
| AU1403402A (en) | Radiopharmaceuticals for diagnosing alzheimer's disease | |
| IL135584A0 (en) | Method for treating alzheimer's disease | |
| HUP0003684A3 (en) | Diagnostic test for alzheimer's disease | |
| IL123834A0 (en) | Diagnostic method and kit for determining rh blood group genotype | |
| AUPN649395A0 (en) | A method for diagnosing alzheimer's disease | |
| AU5153398A (en) | Diagnostic method for the detection of alzheimer's disease in living patients | |
| GB9808867D0 (en) | Referee's computer aid | |
| IL117703A0 (en) | Oral fluid collection kit | |
| AU9017098A (en) | Method for diagnosing alzheimer's disease | |
| GB9706395D0 (en) | Methods for clinical diagnosis | |
| AU2001273675A1 (en) | Methods and assays for diagnosing alzheimer's disease |